MoneyWorks4Me

Revenue reduced marginally to stand at Rs. 674.50 millions during the quarter ended June 2023. The figure stood at Rs. 702.19 millions during the year-ago period.A big decline of -48.38% was reported for the quarter ended June 2023 to Rs. 54.46  millions from Rs. 105.50 millions of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 142.04 millions from 184.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 674.50 702.19 -3.94 674.50 702.19 -3.94 2509.95 4561.32 -44.97
Other Income 3.96 3.77 5.04 3.96 3.77 5.04 29.41 35.12 -16.26
PBIDT 142.04 184.00 -22.80 142.04 184.00 -22.80 632.29 1752.37 -63.92
Interest 21.85 12.19 79.25 21.85 12.19 79.25 60.20 29.17 106.38
PBDT 120.19 171.81 -30.04 120.19 171.81 -30.04 406.80 1723.20 -76.39
Depreciation 47.79 31.31 52.63 47.79 31.31 52.63 149.19 106.44 40.16
PBT 72.40 140.50 -48.47 72.40 140.50 -48.47 257.61 1616.76 -84.07
TAX 17.94 35.00 -48.74 17.94 35.00 -48.74 62.92 416.28 -84.89
Deferred Tax -0.29 0.00 0.00 -0.29 0.00 0.00 1.37 2.75 -50.18
PAT 54.46 105.50 -48.38 54.46 105.50 -48.38 194.69 1200.48 -83.78
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 21.06 26.20 -19.64 21.06 26.20 -19.64 25.19 38.42 -34.43

Kwality Pharma Share Price

2609.05 -43.40 (-1.64%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: